Stock PACIFICORP HOLDINGS LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Pacificorp Holdings Ltd OTC Bulletin Board

Equities

US69512L1098

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Pacificorp Holdings Ltd
2020 Apotheca Biosciences, Inc. cancelled the acquisition of 51% of Hemp Bloom LLC. CI
2019 Apotheca Biosciences, Inc. Announces Resignation of P.C. Sundareswaran as the Chairman and CEO CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Apotheca Biosciences, Inc. cancelled the acquisition of 51% of Hemp Bloom LLC.
CI
Apotheca Biosciences, Inc. Announces Resignation of P.C. Sundareswaran as the Chairman and CEO
CI
Deirdre Fernandes Resigns as VP of Operations and Director of Apotheca Biosciences, Inc
CI
Apotheca Biosciences, Inc. signed a definitive agreement to acquire 51% of Hemp Bloom LLC.
CI
Apotheca Biosciences, Inc. Reports Earnings Results for the First Quarter Ended April 30, 2019
CI
Apotheca Biosciences (CBDC) Introduces XKAPE by ProMED, Our Newest Product Line Designed for Independent Grocers & Convenience Stores -- Wellness to Go
GL
Apotheca Biosciences Introduces XKAPE by ProMED, Newest Product Line Designed for Independent Grocers & Convenience Stores
CI
Apotheca Biosciences, Inc. Announces Resignation of Verghese from Chief Technical Officer and Director
CI
Apotheca Biosciences’ (CBDC) Distribution of ProMED’s Pharma Grade CBD Products Receives Great Response -- Company in Discussion with Wholesalers for Mass Distribution of ProMED CBD Product Lines for an Initial 500 Outlets Nationally
GL
Apotheca Biosciences, Inc. will Change its Ticker to CBDC from PCFP
CI
Apotheca Biosciences Announces the Incorporation of Its Newly Created Subsidiary ProMED Biosciences, Inc
CI
Apotheca Biosciences, Inc. Appoints P.C. Sundar as its Chairman & CEO
CI
Apotheca Biosciences Introduces ProMED
CI
Apotheca Biosciences, Inc. Announces Management Changes
CI
Apotheca Biosciences Signs an LOI For Purchase of Nano Creaciones S.A. P.I. de C.V
CI
Apotheca Biosciences Announces Addition of Dr. Herbert Weissbach to the Cannabis Scientific Advisory Board
CI
Apotheca Biosciences Announces the Addition of Malireddy Srinivasulu Reddy to its Research Team as Chief Medical Advisor
CI
Apotheca Biosciences and CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High
CI
Apotheca Biosciences Inc. Overviews GameDayRx, CBD & Cannabis Tailor-Made for Athletes
CI
Cannabis Leaf, Inc. will Change its Name to Apotheca Biosciences, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CBDC Stock
  4. Stock
  5. News Pacificorp Holdings Ltd